Private Market View

Wugen

Drug Discovery · Saint Louis, MO · Founded 2018 · Privately Held (backing)

PA Mark · $/share
$2
Sep 2026
Implied valuation
$245.0M
Total raised
$323.0M
Last round
Later Stage VC (Series C)
Aug 2025
What is Wugen worth?
$245.0Mlast known valuation

Wugen last raised $115.0M in its Later Stage VC (Series C) (Aug 2025).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·The complete investor list — 13 names
  • ·Watchlist + deal alerts for Wugen
Create free account
No card required

Funding history

2 rounds
DateRoundRaisedPost-money
Aug 2025Later Stage VC (Series C)$115.0M
Dec 2022Early Stage VC (Series B)$172.0M

How Wugen's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Wugen, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →

Frequently asked

What is Wugen worth?
Wugen's implied valuation is $245.0M, based on the PA Mark composite price of about $2 per share as of Sep 2026.
How much has Wugen raised?
Wugen has raised $323.0M in total funding across 2 recorded rounds.
When did Wugen last raise?
Wugen last raised in Aug 2025 (Later Stage VC (Series C)), raising $115.0M.